Why is Alembic Pharma falling/rising?

As of 29-Jul, Alembic Pharmaceuticals Ltd. is currently priced at 1,012.50, reflecting an increase of 8.75 or 0.87%. The stock has shown a positive trend recently, gaining 1.52% over the last two days despite opening with a loss of 2.7% today and touching an intraday low of Rs 976.6. Over the past week, the stock has underperformed the sector by 0.54%, and its one-year return stands at -18.16%. However, the company maintains a strong ability to service its debt, evidenced by a low Debt to EBITDA ratio of 0.67 times, and it is trading at a discount compared to its peers' average historical valuations. High institutional holdings at 20.42% suggest that knowledgeable investors are backing the stock, which may contribute to its recent positive movement.
In the broader market context, Alembic Pharmaceuticals has outperformed the Sensex over the past month, with a return of +3.93% compared to the benchmark's -3.24%. However, the stock's year-to-date performance is notably poor at -4.40%, contrasting with the Sensex's gain of +4.09%. This divergence indicates that while the stock has recently shown some resilience, it still faces challenges in the longer term, particularly given its significant decline over the past year and the overall market conditions.